Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kyverna Therapeutics, Inc.

KYTX Clue Score44
United States Fiscal year ends December CIK 0001994702 Results filed 11 Aug 2026

What the insiders did No buying or selling

By person

14 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Beth C Seidenberg
Director
—
—
—
891,044
$6.68M
+21.1%
Westlake BioPartners Opportunity Fund I, L.P. entity
10% owner
—
—
—
869,317
$6.52M
+18.1%
Christi Shaw
Executive Chairperson
—
—
—
66,741
$500.56K
—
Warner Weston Biddle
Chief Executive Officer
—
—
—
58,000
$435.00K
—
Ryan Alexander Jones
Chief Financial Officer
—
—
—
55,950
$419.63K
+27.3%
Karen Marie Walker
Chief Technology Officer
—
—
—
22,636
$169.77K
+134.9%
Ian T Clark
Director
—
—
—
21,727
$162.95K
—
Fred E Cohen
Director
—
—
—
21,727
$162.95K
—
Mert Aktar
Director
—
—
—
21,727
$162.95K
—
Naji Gehchan
See Remarks
—
—
—
18,000
$135.00K
—
Daniel K Spiegelman
Director
—
—
—
16,634
$124.76K
—
Sravan Kumar Emany
Director
—
—
—
11,006
$82.55K
—
Andrew Craig Miller
Director
—
—
—
11,006
$82.55K
—
Marc Grasso
Chief Financial Officer
—
—
—
10,000
$75.00K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.